Abstract

Minimally invasive continuous glucose monitoring (CGM) sensors are wearable medical devices that provide real-time measurement of subcutaneous glucose concentration. This can be of great help in the daily management of diabetes. Most of the commercially available CGM devices have a wire-based sensor, usually placed in the subcutaneous tissue, which measures a “raw” current signal via a glucose-oxidase electrochemical reaction. This electrical signal needs to be translated in real-time to glucose concentration through a calibration process. For such a scope, the first commercialized CGM sensors implemented simple linear regression techniques to fit reference glucose concentration measurements periodically collected by fingerprick. On the one hand, these simple linear techniques required several calibrations per day, with the consequent patient’s discomfort. On the other, only a limited accuracy was achieved. This stimulated researchers to propose, over the last decade, more sophisticated algorithms to calibrate CGM sensors, resorting to suitable signal processing, modelling, and machine-learning techniques. This review paper will first contextualize and describe the calibration problem and its implementation in the first generation of CGM sensors, and then present the most recently-proposed calibration algorithms, with a perspective on how these new techniques can influence future CGM products in terms of accuracy improvement and calibration reduction.

Highlights

  • Diabetes is a chronic disorder that occurs either when the pancreas is no longer able to produce insulin, or if body tissues and organs cannot effectively utilize circulating insulin

  • The aim of the present paper is to review the calibration algorithms proposed for minimally-invasive continuous glucose monitoring (CGM) sensors with a perspective on how these new techniques can influence future CGM products

  • By taking into account blood glucose (BG)-to-interstitial glucose (IG) kinetics, using a model to describe the variability of sensor sensitivity, and exploiting four BG reference samples per day, the method significantly improves CGM

Read more

Summary

Introduction

Diabetes is a chronic disorder that occurs either when the pancreas is no longer able to produce insulin (type 1 diabetes, T1D), or if body tissues and organs cannot effectively utilize circulating insulin (type 2 diabetes, T2D). The total number of cases of diabetes is expected to exceed 500 million by 2030, becoming one of the most challenging socio-health emergencies of the third millennium It is not possible with current knowledge to definitely cure diabetes, a constant and appropriate management of the disease can control and prevent many complications [6,8,9]. SMBG-based monitoring, consequent improvement of glycemic control, quality to of standard life, and consecutive days, greatly with increasing the information on glucose dynamics compared reduction of diabetes-related complications [19,20,21,22,23,24,25,26]. SMBG-based monitoring, with consequent improvement of glycemic control, quality of line) life, the andofhyperglycemic episodes detected by the Dexcom

Platinum
Problem Statement
Examples
Critical
Representative
State-of-the-Art
Current Perspectives
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.